Francesco Passiglia

Papers

Total Citations

H-Index

About

Francesco Passiglia is a leading oncologist and researcher whose work centers on thoracic malignancies, particularly lung cancer, with a focus on precision medicine, immunotherapy, and biomarker-driven treatment strategies. His major contributions include advancing the understanding of molecular profiling in non-small cell lung cancer (NSCLC) and the clinical integration of immune checkpoint inhibitors, helping to refine patient selection for targeted therapies. His highly cited paper, "Lung Cancer in Italy" (2019, 24 citations), provides a comprehensive epidemiological and clinical overview of the disease in the Italian context, highlighting regional disparities and treatment outcomes. Beyond this, Passiglia has been instrumental in collaborative studies exploring resistance mechanisms to EGFR inhibitors and the role of liquid biopsies in real-time tumor monitoring. His work has shaped national guidelines and influenced clinical practice, earning him recognition as a key voice in the Italian lung cancer research community. With a growing citation impact, Passiglia continues to bridge translational research and bedside care, driving progress in one of oncology’s most challenging fields.